BLFS (BioLife Solutions, Inc.) Stock Financials & Earnings

BLFSBioLife Solutions, Inc.

Mkt Cap$921M

Revenue (TTM)$96M

Net Income (TTM)-$12M

EPS (TTM)-$0.25

Free Cash Flow (TTM)$13M

Gross Margin64.6%

Op. Margin-12.6%

Net Margin-12.6%

FCF Margin13.3%

P/S Ratio (TTM)9.6x

P/E Ratio (TTM)—

YoY Rev Growth+47.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$38M	$14M	-$13M
Q2 23	$40M	$12M	-$15M
Q3 23	$24M	$12M	-$9M
Q4 23	$17M	$9M	-$7M
Q1 24	$18M	$12M	-$3M
Q2 24	$20M	$13M	-$4M
Q3 24	$31M	$22M	-$2M
Q4 24	-$3M	$8M	$1M
Q1 25	$24M	$16M	-$1M
Q2 25	$25M	$16M	-$17M
Q3 25	$28M	$17M	-$89K
Q4 25	$19M	$13M	$6M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$4M	$15M	$6M
Q2 23	$5M	$15M	$6M
Q3 23	$5M	$13M	$5M
Q4 23	$4M	$13M	$5M
Q1 24	$4M	$10M	$2M
Q2 24	$2M	$9M	$2M
Q3 24	$2M	$11M	$4M
Q4 24	$1M	$7M	—
Q1 25	$2M	$12M	$3M
Q2 25	$3M	$11M	$3M
Q3 25	$3M	$12M	$3M
Q4 25	$66K	$11M	$2M

Revenue Segments

Quarter	Product	Rental Revenue	Service
Q1 25	$22M	$2M	$60K
Q2 25	$24M	$2M	$36K
Q3 25	$26M	$2M	$26K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$19M	$36M	$55M
Q2 23	$21M	$25M	$46M
Q3 23	$19M	$22M	$41M
Q4 23	$28M	$16M	$44M
Q1 24	$30M	$16M	$45M
Q2 24	$22M	$12M	$34M
Q3 24	$24M	$10M	$34M
Q4 24	$95M	$9M	$105M
Q1 25	$67M	$22M	$89M
Q2 25	$32M	$50M	$82M
Q3 25	$29M	$49M	$79M
Q4 25	$0	$120M	$120M

Shares Outstanding

Revenue Per Employee

Revenue / Employee